Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pediatric Brain Tumor Consortium
With
National Cancer Institute (NCI)
OBJECTIVES:
Primary
* Evaluate the fraction of peripherally circulating T-regulatory cells (T\_regs) in pediatric patients with newly diagnosed medulloblastoma and compare it to the levels found in a control group of patients undergoing craniectomy for Chiari malformation.
* Evaluate the longitudinal effects of standard radiotherapy and chemotherapy regimens on the overall population of lymphocytes as well as the fraction of T\_reg cells in patients with medulloblastoma.
Secondary
* Determine the baseline fraction of T\_reg cells in those with non-medulloblastoma posterior fossa tumors compared to levels found in patients undergoing decompression for Chiari malformation.
OUTLINE: This is a multicenter study.
Patients with Chiari malformation and patients with posterior fossa tumor undergo standard surgery. Patients with posterior fossa tumor also receive standard radiotherapy and chemotherapy.
Blood samples are collected at baseline and periodically to measure the level of circulating T-regulatory cells.
Age
4–21
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DISEASE CHARACTERISTICS:
Meets 1 of the following criteria:
* Histologically confirmed posterior fossa tumor
* Newly diagnosed disease
* Medulloblastoma OR non-medulloblastoma (pilocytic astrocytoma, ependymoma, atypical rhabdoid tumor, or others)
* Scheduled to undergo craniotomy and tumor resection
* Chiari malformation
* Requires craniectomy for decompression
* No secondary decompression
PATIENT CHARACTERISTICS:
No unexplained febrile illness
No active infection
No autoimmune disorders such as inflammatory bowel disease, juvenile rheumatoid arthritis, or systemic lupus erythematosus
No other immunosuppressive disorders (e.g., HIV infection)
PRIOR CONCURRENT THERAPY:
See Disease Characteristics
Clareo Health | Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy